0.70 0.00 0.00%
Official Close 3/17/2023 NAS

On Friday 03/17/2023 the closing price of the Coronado Biosciences Inc share was $0.70 on NAS. Compared to the opening price on Friday 03/17/2023 on NAS of $0.73, this is a drop of 4.30%. Coronado Biosciences Inc's market capitalization is $79.78 M by 110.49 M shares outstanding.
Is Coronado Biosciences stock a Buy, Sell or Hold? Coronado Biosciences stock hasn't recieved a clear consensus rating. The average rating score is and is based on 1 buy ratings, 1 hold ratings, and 0 sell ratings.
What was the 52-week low for Coronado Biosciences stock? The low in the last 52 weeks of Coronado Biosciences stock was 0.48. According to the current price, Coronado Biosciences is 145.74% away from the 52-week low.
What was the 52-week high for Coronado Biosciences stock? The high in the last 52 weeks of Coronado Biosciences stock was 1.53. According to the current price, Coronado Biosciences is 45.90% away from the 52-week high.
What are analysts forecasts for Coronado Biosciences stock? The 2 analysts offering price forecasts for Coronado Biosciences have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a 12.73 difference from the last price of 0.70.

Coronado Biosciences Stock Snapshot

0.73
Bid
800.00
Bid Size
0.74
Ask
2,800.00
Ask Size
3/17/2023
Date
8:00 PM
Time
284,728.00
Volume
0.74
Prev. Close
0.73
Open
79.78 M
Market Cap
110.49 M
Number of Shares
0.70
Day Low
0.74
Day High
0.70
0.48
52 Week Low
1.53
52 Week High
0.70
-3.05
P/E Ratio
58.26
Free Float in %
-0.84
EPS 2023

Coronado Biosciences Historical Prices

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Coronado Biosciences Analyst Data

Total Analysts: 2
Buy Ratings: 1 Neutral Ratings: 1 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 5.00 Median: 5.50 Highest: 6.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Coronado Biosciences Analyst Opinions

08/04/22 Ladenburg Thalmann & Co. Inc.
Maintained Buy $6
04/20/21 ROTH Capital Partners, LLC
Maintained Buy $5

Coronado Biosciences Estimates* in USD

  2023 2024 2025 2026
Revenue 86 163 254 380
Dividend - - - -
Dividend Yield (in %) - - - -
EPS -0.84 0.24 0.49 1.69
P/E Ratio -0.87 2.98 1.47 0.43
EBIT -190 -138 -63 33
EBITDA -252 - - -
Net Profit -96 8 25 136
Net Profit Adjusted -145 -65 -54 33
Pre-Tax Profit -204 -152 -73 23
Net Profit (Adjusted) -128 -95 2 -
EPS (Non-GAAP) ex. SOE -0.58 1.59 - -
EPS (GAAP) -0.84 0.24 0.49 1.69
Gross Income 76 172 210 266
Cash Flow from Investing -4 -4 -4 -5
Cash Flow from Operations -203 -152 -76 -37
Cash Flow from Financing 118 135 140 88
Cash Flow per Share - - - -
Free Cash Flow - - - -
Free Cash Flow per Share - - - -
Book Value per Share - - - -
Net Debt - - - -
Research & Development Exp. 143 153 151 171
Capital Expenditure 4 4 4 5
Selling, General & Admin. Exp. 127 142 151 163
Shareholder’s Equity 74 87 113 154
Total Assets 285 312 361 409
  Previous Quarter
ending 12/31/22
Current Quarter
ending 03/31/23
Next Quarter
ending 06/30/23
Current Year
ending 12/31/23
Next Year
ending 12/31/24
Earnings Estimates
No. of Analysts - 3 3 5 5
Average Estimate - -0.207 USD -0.210 USD -0.836 USD 0.244 USD
Year Ago - -0.180 USD -0.240 USD - -0.836 USD
Publish Date - 5/11/2023 8/10/2023 - -
Revenue Estimates
No. of Analysts 5 3 3 5 5
Average Estimate 22 USD 18 USD 18 USD 86 USD 163 USD
Year Ago 18 USD 24 USD 19 USD - 86 USD
Publish Date 3/20/2023 5/11/2023 8/10/2023 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Coronado Biosciences Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
Lu Lucy 02/09/2023 11,976.00 133,379.00 0.84 Buy No
Jin David 02/09/2023 35,928.00 1,438,757.00 0.84 Buy No
ROSENWALD LINDSAY A MD 02/09/2023 2,395,209.00 15,349,091.00 0.84 Buy No
Rowinsky Eric K 02/09/2023 11,976.00 931,976.00 0.84 Buy No
WEISS MICHAEL S 02/09/2023 1,197,604.00 14,752,034.00 0.84 Buy No
LOBELL J JAY 02/09/2023 299,401.00 1,635,401.00 0.84 Buy No
LOBELL J JAY 12/31/2022 100,000.00 1,336,000.00 n/a Buy No
Harvey Jimmie 12/31/2022 100,000.00 950,000.00 n/a Buy No
ROSENWALD LINDSAY A MD 12/31/2022 1,219,294.00 12,953,882.00 n/a Buy No
WEISS MICHAEL S 12/31/2022 1,219,294.00 13,554,430.00 n/a Buy No
Hoenlein Malcolm 12/31/2022 50,000.00 535,636.00 n/a Buy No
Lu Lucy 12/31/2022 50,000.00 121,403.00 n/a Buy No
Rowinsky Eric K 12/31/2022 100,000.00 920,000.00 n/a Buy No
Lorenz Kevin 12/31/2022 50,000.00 314,572.00 n/a Buy No
Klein Dov 12/31/2022 100,000.00 851,015.00 n/a Buy No
Lu Lucy 12/15/2022 30,000.00 71,403.00 n/a Buy No
ROSENWALD LINDSAY A MD 11/30/2022 100,000.00 11,730,324.00 0.68 Buy No
ROSENWALD LINDSAY A MD 11/29/2022 5,000.00 11,630,324.00 0.56 Buy No
Jin David 11/29/2022 5,000.00 1,402,829.00 0.56 Buy No
Jin David 10/25/2022 1,350,000.00 1,397,829.00 n/a Buy No
ROSENWALD LINDSAY A MD 10/20/2022 100,000.00 11,625,324.00 0.70 Buy No
ROSENWALD LINDSAY A MD 05/31/2022 4,264.00 11,734,588.00 0.73 Buy No
LOBELL J JAY 12/31/2021 100,000.00 1,236,000.00 n/a Buy No
Rowinsky Eric K 12/31/2021 100,000.00 820,000.00 n/a Buy No
Klein Dov 12/31/2021 100,000.00 751,015.00 n/a Buy No

Coronado Biosciences Dividend Calendar

Date Name Dividend *yield Currency
2021 Coronado Biosciences Inc - - USD
2020 Coronado Biosciences Inc - - USD
2019 Coronado Biosciences Inc - - USD
2018 Coronado Biosciences Inc - - USD
2017 Coronado Biosciences Inc - - USD
2016 Coronado Biosciences Inc - - USD
2015 Coronado Biosciences Inc - - USD
2014 Coronado Biosciences Inc - - USD
2013 Coronado Biosciences Inc - - USD
2012 Coronado Biosciences Inc - - USD
2011 Coronado Biosciences Inc - - USD
2010 Coronado Biosciences Inc - - USD
2009 Coronado Biosciences Inc - - USD
*Yield of the Respective Date

Coronado Biosciences Inc Calendar

Event Estimate Info Date
Earnings Report - Q4 2022 Earnings Release 03/20/2023
Earnings Report -0.207 USD Q1 2023 Earnings Release 05/11/2023
Earnings Report -0.210 USD Q2 2023 Earnings Release 08/10/2023
Earnings Report - Q3 2023 Earnings Release 11/13/2023

Coronado Biosciences Profile

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
9
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Coronado Biosciences Shareholder

Owner in %
Freefloat 62.15
Lindsay Allan Rosenwald, MD 13.89
Michael Sean Weiss 13.35
Nantahala Capital Management LLC 7.21
DAK Capital, Inc. 5.48
Vanguard Group, Inc. (Subfiler) 4.59
Jefferies Financial Services, Inc. 3.89
Tang Capital Management LLC 3.80
Vanguard Total Stock Market Index Fund 1.94
Opaleye Management, Inc. 1.86
Vanguard Explorer Fund 1.57
J. Jay Lobell 1.48
iShares Russell 2000 ETF 1.44
David Jin 1.30
FCP Medical - BioHealth 1.19
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.